ARQT icon

Arcutis Biotherapeutics

139 hedge funds and large institutions have $1.06B invested in Arcutis Biotherapeutics in 2022 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 68 increasing their positions, 19 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
139
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5.86M
Puts
$349K
Net Calls
Net Calls Change

Top Sellers

1 -$13.3M
2 -$9.18M
3 -$5.23M
4
Invesco
Invesco
Georgia
-$3.64M
5
Citadel Advisors
Citadel Advisors
Florida
-$2.14M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$478K
77
$470K
78
$461K
79
$450K
80
$442K
81
$423K
82
$416K
83
$371K
84
$365K
85
$365K
86
$356K
87
$351K
88
$348K
89
$308K
90
$292K
91
$291K
92
$272K
93
$266K
94
$263K
95
$256K
96
$251K
97
$250K
98
$247K
99
$242K
100
$228K